[
  {
    "date": "2023-12-30",
    "symbol": "TSHA",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "2023-12-31",
    "documentfiscalyearfocus": 2023,
    "documentfiscalperiodfocus": "FY",
    "tradingsymbol": "TSHA",
    "entityregistrantname": "Taysha Gene Therapies, Inc.",
    "entitycentralindexkey": 1806310,
    "currentfiscalyearenddate": "--12-31",
    "entitycurrentreportingstatus": "Yes",
    "entityfilercategory": "Non-accelerated Filer",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "true",
    "entityextransitionperiod": "false",
    "entityshellcompany": "false",
    "entityfilenumber": "001-39536",
    "entitytaxidentificationnumber": "84-3199512",
    "entityaddressaddressline1": "3000 Pegasus Park Dr",
    "entityaddressaddressline2": "Ste 1430",
    "entityaddresscityortown": "Dallas",
    "entityaddressstateorprovince": "TX",
    "entityaddresspostalzipcode": 75247,
    "cityareacode": 214,
    "localphonenumber": "612-0000",
    "security12btitle": "Common stock, par value $0.00001 per share",
    "securityexchangename": "NASDAQ",
    "entityincorporationstatecountrycode": "DE",
    "entityinteractivedatacurrent": "Yes",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "icfrauditorattestationflag": "false",
    "documentfinstmterrorcorrectionflag": "false",
    "auditorname": "Deloitte & Touche LLP",
    "auditorlocation": "Dallas, Texas",
    "auditorfirmid": 34,
    "cashandcashequivalentsatcarryingvalue": 143940000,
    "restrictedcashcurrent": 449000,
    "prepaidexpenseandotherassetscurrent": 3479000,
    "assetsheldforsalenotpartofdisposalgroupcurrent": 2000000,
    "assetscurrent": 149868000,
    "restrictedcashnoncurrent": 2151000,
    "propertyplantandequipmentnet": 10826000,
    "operatingleaserightofuseasset": 9582000,
    "otherassetsnoncurrent": 304000,
    "assets": 172731000,
    "accountspayablecurrent": 6366000,
    "accruedliabilitiesandotherliabilities": 12284000,
    "deferredrevenuecurrent": 18106000,
    "liabilitiescurrent": 36756000,
    "longtermdebtnoncurrent": 40508000,
    "operatingleaseliabilitynoncurrent": 18953000,
    "otherliabilitiesnoncurrent": 1577000,
    "liabilities": 97794000,
    "commonstockvalue": 2000,
    "additionalpaidincapital": 587942000,
    "retainedearningsaccumulateddeficit": -513007000,
    "stockholdersequity": 74937000,
    "liabilitiesandstockholdersequity": 172731000,
    "preferredstockparorstatedvaluepershare": 0.00001,
    "preferredstocksharesauthorized": 10000000,
    "commonstockparorstatedvaluepershare": 0.00001,
    "commonstocksharesauthorized": 400000000,
    "commonstocksharesissued": 186960193,
    "commonstocksharesoutstanding": 186960193,
    "revenues": 15451000,
    "researchanddevelopmentexpense": 56778000,
    "generalandadministrativeexpense": 30047000,
    "impairmentoflonglivedassetsheldforuse": 1065000,
    "operatingexpenses": 87890000,
    "operatingincomeloss": -72439000,
    "changeinfairvalueofwarrantliability": 34718000,
    "gainslossesonextinguishmentofdebt": -1398000,
    "changeinfairvalueoftermloan": 1538000,
    "interestincomeexpensenonoperatingnet": 3572000,
    "interestexpense": 4998000,
    "othernonoperatingincomeexpense": -47000,
    "nonoperatingincomeexpense": -39127000,
    "netincomeloss": -111566000,
    "earningspersharebasic": -0.96,
    "earningspersharediluted": -0.96,
    "weightedaveragenumberofsharesoutstandingbasic": 116121482,
    "weightedaveragenumberofdilutedsharesoutstanding": 116121482,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 7905000,
    "stockissuedduringperiodvaluenewissues": 1000,
    "stockissuedduringperiodsharesnewissues": 123117594,
    "issuanceofcommonstockuponvestingandsettlementofrestrictedstockunitshares": 566772,
    "stockissuedduringperiodvalueemployeestockpurchaseplan": 68000,
    "stockissuedduringperiodsharesemployeestockpurchaseplans": 68320,
    "reclassificationofprefundedwarrantstoequityclassification": 74342000,
    "adjustmentstoadditionalpaidincapitalstockissuedissuancecosts": 7138000,
    "profitloss": -111566000,
    "depreciation": 1371000,
    "researchanddevelopmentlicenseexpense": 3500000,
    "sharebasedcompensation": 7905000,
    "fairvalueadjustmentofwarrants": 34718000,
    "issuancecostsforprefundedwarrantliability": 2567000,
    "noncashgainlossonextinguishmentofdebt": -1366000,
    "noncashchangeinfairvalueoftermloan": 1278000,
    "debtissuancecostsexpensedunderfairvalueoption": 867000,
    "operatingleaserightofuseassetamortizationexpense": 1182000,
    "othernoncashincomeexpense": -741000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": -6011000,
    "increasedecreaseinaccountspayable": -2295000,
    "increasedecreaseinaccruedexpenseandotherliabilities": -6277000,
    "increasedecreaseincontractwithcustomerliability": -15451000,
    "netcashprovidedbyusedinoperatingactivities": -73018000,
    "paymentstoacquireinprocessresearchanddevelopment": 3500000,
    "paymentstoacquirepropertyplantandequipment": 3869000,
    "paymentsforproceedsfromotherinvestingactivities": -17000,
    "netcashprovidedbyusedininvestingactivities": -7352000,
    "proceedsfromtrinitytermloannet": 39550000,
    "paymentsofdebtissuancecosts": 399000,
    "repaymentofsvbtermloan": 43000000,
    "proceedsfromissuanceofcommonstock": 500000,
    "proceedsfromissuanceofcommonstockandprefundedwarrantsfromprivateplacementnetofplacementagentcommissionsandotherofferingcosts": 140290000,
    "paymentsofstockissuancecosts": 387000,
    "proceedsfromstockplans": 68000,
    "proceedsfrompaymentsforotherfinancingactivities": -229000,
    "netcashprovidedbyusedinfinancingactivities": 136393000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": 56023000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 146540000,
    "restrictedcash": 2600000,
    "interestpaidnet": 4952000,
    "adjustmentstoadditionalpaidincapitalwarrantissued": 74342000,
    "allocationofproceedstosuccessfeeliability": 770000,
    "settlementofassetretirementobligationsthroughnoncashpaymentsamount": 449000,
    "capitalexpendituresincurredbutnotyetpaid": 18000,
    "issuanceofwarrantsinconnectionwithprivateplacement": 252000,
    "entityincorporationdateofincorporation": "2020-02-13",
    "cashequivalentsatcarryingvalue": 142400000,
    "shelfregistrationterm": "P3Y",
    "propertyplantandequipmentusefullife": "P3Y",
    "assetimpairmentcharges": 600000,
    "cumulativeearningsdeficit": 200000,
    "unrecognizedtaxbenefitsperiodincreasedecrease": 400000,
    "unrecognizedtaxbenefitsdecreasesresultingfrompriorperiodtaxpositions": 7800000,
    "derecognizedbuildtosuitleaseassetpresentedinpropertyplantequipment": 26300000,
    "deferredrentliabiilitiesandtenantimprovementallowances": 700000,
    "changeinaccountingprincipleaccountingstandardsupdateadopted": "true",
    "changeinaccountingprincipleaccountingstandardsupdateadoptiondate": "2022-01-01",
    "changeinaccountingprincipleaccountingstandardsupdateimmaterialeffect": "false",
    "operatingleaseliability": 19100000,
    "derecognizedbuildtosuitleaseliability": 26500000,
    "cashandcashequivalentsfairvaluedisclosure": 142425000,
    "assetsfairvaluedisclosure": 142425000,
    "trinitytermloans": 40508000,
    "successfeederivativeliability": 800000,
    "ssiwarrants": 454000,
    "liabilitiesfairvaluedisclosure": 41762000,
    "propertyplantandequipmentgross": 2117000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 2979000,
    "gainlossonsalesofassetsandassetimpairmentcharges": -600000,
    "accruedresearchanddevelopmentcurrent": 3467000,
    "employeerelatedliabilitiescurrent": 3423000,
    "accruedclinicaltrialcurrent": 1851000,
    "leaseliabilitycurrent": 1646000,
    "warrantliabilitycurrent": 454000,
    "accruedseverance": 390000,
    "accruedprofessionalfeescurrent": 330000,
    "otheraccruedliabilitiescurrent": 723000,
    "prepaidresearchanddevelopmentcontracts": 1412000,
    "prepaidclinicaltrial": 802000,
    "deferredofferingcosts": 681000,
    "prepaidinsurance": 292000,
    "otherassetscurrent": 292000,
    "lesseeoperatingleaseoptiontoextend": "The Company has two options to extend the term of the Durham Lease, each for a period of an additional five years.",
    "lesseeoperatingleaseliabilitypaymentsdue": 30500000,
    "escrowdeposit": 2600000,
    "operatingleasecost": 2770000,
    "variableleasecost": 960000,
    "leasecost": 3730000,
    "financeleaseweightedaverageremainingleaseterm1": "P2Y10M17D",
    "operatingleaseweightedaverageremainingleaseterm1": "P10Y9M",
    "financeleaseweightedaveragediscountratepercent": 0.1052,
    "operatingleaseweightedaveragediscountratepercent": 0.078,
    "operatingleasepayments": 2824000,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 2810000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 2910000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 2485000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfour": 2577000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfive": 2673000,
    "lesseeoperatingleaseliabilitypaymentsdueafteryearfive": 17045000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 10255000,
    "operatingleaseliabilitycurrent": 1292000,
    "operatingleaseliabilitycurrentstatementoffinancialpositionextensiblelist": "http://fasb.org/us-gaap/2023#AccruedLiabilitiesAndOtherLiabilities",
    "financeleaseliabilitypaymentsduenexttwelvemonths": 454000,
    "financeleaseliabilitypaymentsdueyeartwo": 454000,
    "financeleaseliabilitypaymentsdueyearthree": 325000,
    "financeleaseliabilitypaymentsdueyearfour": 73000,
    "financeleaseliabilitypaymentsdue": 1306000,
    "financeleaseliabilityundiscountedexcessamount": 174000,
    "financeleaseliability": 1132000,
    "financeleaseliabilitycurrent": 354000,
    "financeleaseliabilitycurrentstatementoffinancialpositionextensiblelist": "http://fasb.org/us-gaap/2023#AccruedLiabilitiesAndOtherLiabilities",
    "financeleaseliabilitynoncurrent": 778000,
    "financeleaseliabilitynoncurrentstatementoffinancialpositionextensiblelist": "http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent",
    "financeleaseliabilitystatementoffinancialpositionextensiblelist": "http://fasb.org/us-gaap/2023#Liabilities",
    "lineofcreditfacilitymaximumborrowingcapacity": 20000000,
    "longtermdebt": 40000000,
    "deferredfinancecostsgross": 900000,
    "debtinstrumentfairvalue": 39200000,
    "debtinstrumentmaturitydaterangeend1": "2022-09-30",
    "percentageofcalculateddiscountedcashflowsofdiscountrate": 0.1568,
    "debtinstrumentunamortizeddiscountnoncurrent": 3000000,
    "prepaymentoflongtermdebt": 43200000,
    "paymentofexitfee": 3000000,
    "debtinstrumentincreaseaccruedinterest": 200000,
    "remainingbalanceofdebtdiscount": 1400000,
    "interestexpenselongtermdebt": 4900000,
    "longtermdebtmaturitiesrepaymentsofprincipalinyearfour": 18709000,
    "longtermdebtmaturitiesrepaymentsofprincipalinyearfive": 21291000,
    "debtinstrumentcarryingamount": 40000000,
    "upfrontpayment": 20000000,
    "transactionprice": 36100000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardtermsofaward": "The number of shares of common stock reserved for issuance under the New Plan automatically increases on January 1 of each year, for a period of ten years, from January 1, 2021, continuing through January 1, 2030, by 5% of the total number of shares of common stock outstanding on December 31 of the preceding calendar year, or a lesser number of shares as may be determined by the Company’s board of directors.",
    "commonstockcapitalsharesreservedforfutureissuance": 4000000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": "P10Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 2726871,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 2050562,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "P1Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 0.71,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 8400000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P1Y10M24D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 5960922,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 332532,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedsharebasedawardsotherthanoptions": 1400000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 1.06,
    "allocatedsharebasedcompensationexpense": 100000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeitedinperiod": 658343,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 556989,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 3162725,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrantplanadjustmentsandamendmentsinperiod": -667828,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrantgrantedinperiod": 5447757,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrantcancelledinperiod": 667828,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0368,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P5Y6M",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.82,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexpirationsinperiod": 873465,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisablenumber": 1580373,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 5.75,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 0.99,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 10.7,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexpirationsinperiodweightedaverageexerciseprice": 22.21,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 13.51,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P8Y8M12D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P7Y7M6D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 1960000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 8000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 375044,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 6.63,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 4.78,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeituresweightedaveragegrantdatefairvalue": 5.18,
    "incurredplacementagentcommissionsandotherissuancecosts": 9700000,
    "allocatedtosharesdeductiontoadditionalpaidincapital": 7100000,
    "classofwarrantorrightvestedandexercisable": 316667,
    "reclassificationofwarrantliabilityclassifiedprefundedwarrantstoequityclassified": 74300000,
    "commonstockandwarrantsfairvaluedisclosure": 110127,
    "warrantsandrightsoutstandingmeasurementinput": 3.84,
    "warrantliabilityfairvaluedisclosure": 454000,
    "issuanceofwarrantliability": 252000,
    "changeinfairvalueofwarrants": 34718000,
    "netincomelossavailabletocommonstockholdersbasic": -111566000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 375044,
    "researchandexperimentationexpendituresamortizedperiod": "P5Y",
    "effectiveincometaxratereconciliationtaxcredits": 0.15,
    "excisetaxratepercentage": 0.01,
    "valuationallowancedeferredtaxassetchangeinamount": -9000000,
    "operatinglosscarryforwards": 222100000,
    "operatinglosscarryforwardslimitationsonuse": "federal NOLs are subject to an annual utilization limitation of $3.1 million, which can be increased in the five year period post change date for any realized built-in gain.",
    "operatinglosscarryforwardannuallimitationamount": 3100000,
    "deferredtaxassetstaxcreditcarryforwards": 1961000,
    "taxcreditcarryforwardexpirationorduedateyear": 2040,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 27100000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.0033,
    "effectiveincometaxratereconciliationnondeductibleexpenseresearchanddevelopment": -0.1898,
    "effectiveincometaxratereconciliationotherpermanentdifferences": -0.0067,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": 0.081,
    "effectiveincometaxratereconciliationchangeinfairvalueofwarrantliability": -0.0655,
    "effectiveincometaxratereconciliationchangeinfairvalueoftermnote": -0.003,
    "effectiveincometaxratereconciliationsharebasedcompensationexcesstaxbenefitpercent": -0.0293,
    "deferredtaxassetsoperatinglosscarryforwards": 47373000,
    "deferredtaxassetstaxdeferredexpensereservesandaccruals": 1020000,
    "deferredtaxassetstaxdeferredexpenseother": 3978000,
    "deferredtaxassetsgoodwillandintangibleassets": 4888000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefits": 2585000,
    "deferredtaxassetsinprocessresearchanddevelopment": 22497000,
    "deferredtaxassetsleaseliabilities": 4452000,
    "deferredtaxassetsimpairmentoflonglivedassets": 5509000,
    "deferredtaxassetsgross": 94263000,
    "deferredtaxliabilitiesleasingarrangements": 2224000,
    "deferredtaxliabilitiespropertyplantandequipment": 2000,
    "deferredtaxliabilities": 2226000,
    "deferredtaxassetsvaluationallowance": 92037000,
    "severancecosts1": -3764000,
    "accruedseverancebalance": 390000,
    "severancecostrecorded": 2691000,
    "definedcontributionplanemployerdiscretionarycontributionamount": 300000
  },
  {
    "date": "2022-12-30",
    "symbol": "TSHA",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "December 31, 2022",
    "documentfiscalyearfocus": 2022,
    "documentfiscalperiodfocus": "FY",
    "tradingsymbol": "TSHA",
    "entityregistrantname": "Taysha Gene Therapies, Inc.",
    "entitycentralindexkey": 1806310,
    "currentfiscalyearenddate": "December 31",
    "entitycurrentreportingstatus": "Yes",
    "entityfilercategory": "Non-accelerated filer",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "true",
    "entityextransitionperiod": "false",
    "entityshellcompany": "true",
    "entityfilenumber": "001-39536",
    "entitytaxidentificationnumber": "84-3199512",
    "entityaddressaddressline1": "3000 Pegasus Park Dr",
    "entityaddressaddressline2": "Ste 1430",
    "entityaddresscityortown": "Dallas",
    "entityaddressstateorprovince": "Texas",
    "entityaddresspostalzipcode": 75247,
    "cityareacode": 214,
    "localphonenumber": "612-0000",
    "security12btitle": "Common stock, par value $0.00001 per share",
    "securityexchangename": "The Nasdaq Stock Market LLC",
    "entityincorporationstatecountrycode": "Delaware",
    "entityinteractivedatacurrent": "Yes",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "icfrauditorattestationflag": "false",
    "auditorname": "Deloitte & Touche LLP",
    "auditorlocation": "Dallas, Texas",
    "auditorfirmid": 34,
    "cashandcashequivalentsatcarryingvalue": 87880000,
    "prepaidexpenseandotherassetscurrent": 8537000,
    "assetscurrent": 96417000,
    "restrictedcash": 2637000,
    "propertyplantandequipmentnet": 1300000,
    "operatingleaserightofuseasset": 18400000,
    "otherassetsnoncurrent": 1316000,
    "assets": 126276000,
    "accountspayablecurrent": 10946000,
    "accruedliabilitiesandotherliabilities": 18287000,
    "deferredrevenuecurrent": 33557000,
    "liabilitiescurrent": 62790000,
    "longtermdebtnoncurrent": 37967000,
    "operatingleaseliabilitynoncurrent": 20440000,
    "otherliabilitiesnoncurrent": 4130000,
    "liabilities": 125327000,
    "commonstockvalue": 1000,
    "additionalpaidincapital": 402389000,
    "retainedearningsaccumulateddeficit": -401441000,
    "stockholdersequity": -401441000,
    "liabilitiesandstockholdersequity": 126276000,
    "preferredstockparorstatedvaluepershare": 0.00001,
    "preferredstocksharesauthorized": "null",
    "commonstockparorstatedvaluepershare": 0.00001,
    "commonstocksharesauthorized": "null",
    "commonstocksharesissued": "null",
    "commonstocksharesoutstanding": "null",
    "revenues": 2502000,
    "researchanddevelopmentexpense": 1000000,
    "generalandadministrativeexpense": 37360000,
    "impairmentoflonglivedassetsheldforuse": 36420000,
    "operatingexpenses": 164949000,
    "operatingincomeloss": -162447000,
    "interestincomeexpensenonoperatingnet": 249000,
    "interestexpense": 3798000,
    "othernonoperatingexpense": 18000,
    "nonoperatingincomeexpense": -3567000,
    "netincomeloss": -166014000,
    "earningspersharebasic": -3.78,
    "earningspersharediluted": -3.78,
    "weightedaveragenumberofsharesoutstandingbasic": "null",
    "weightedaveragenumberofdilutedsharesoutstanding": "null",
    "accountingstandardsupdateextensiblelist": "http://fasb.org/us-gaap/2022#AccountingStandardsUpdate201602Member",
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 18275000,
    "stockissuedduringperiodvaluenewissues": 11609000,
    "stockissuedduringperiodsharesnewissues": "null",
    "issuanceofcommonstockuponvestingandsettlementofrestrictedstockunitshares": 628921,
    "stockissuedduringperiodvalueemployeestockpurchaseplan": 253000,
    "stockissuedduringperiodsharesemployeestockpurchaseplans": 73073,
    "adjustmentstoadditionalpaidincapitalstockissuedissuancecosts": 187000,
    "paymentofsalescommissionsandotherofferingcosts": 392000,
    "underwritingdiscountandotherofferingcosts": 2072000,
    "profitloss": -166014000,
    "depreciation": 1172000,
    "researchanddevelopmentinprocess": 1250000,
    "sharebasedcompensation": 18043000,
    "operatingleaserightofuseassetamortizationexpense": 1315000,
    "othernoncashincomeexpense": -906000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": -2088000,
    "increasedecreaseinaccountspayable": -7804000,
    "increasedecreaseinaccruedexpenseandotherliabilities": -9323000,
    "increasedecreaseincontractwithcustomerliability": 33557000,
    "netcashprovidedbyusedinoperatingactivities": -88390000,
    "paymentstoacquireinprocessresearchanddevelopment": 4250000,
    "paymentstoacquirepropertyplantandequipment": 20619000,
    "paymentsforproceedsfromotherinvestingactivities": 61000,
    "netcashprovidedbyusedininvestingactivities": -24930000,
    "proceedsfromissuanceofcommonstock": 11640000,
    "paymentofshelfregistrationcosts": 358000,
    "proceedsfromstockplans": 253000,
    "proceedsfrompaymentsforotherfinancingactivities": -1042000,
    "netcashprovidedbyusedinfinancingactivities": 52097000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -61223000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 90517000,
    "interestpaidnet": 2775000,
    "propertyandequipmentinaccountspayableandaccruedexpenses": 4002000,
    "rightofuseassetobtainedinexchangeforfinanceleaseliability": 23432000,
    "capitalexpendituresincurredbutnotyetpaid": 387000,
    "entityincorporationdateofincorporation": "February 13, 2020",
    "upfrontpayment": 20000000,
    "shelfregistrationterm": "three-year",
    "propertyplantandequipmentusefullife": "seven years",
    "cumulativeearningsdeficit": 200000,
    "unrecognizedtaxbenefitsperiodincreasedecrease": 3100000,
    "derecognizedbuildtosuitleaseassetpresentedinpropertyplantequipment": 26300000,
    "deferredrentliabiilitiesandtenantimprovementallowances": 700000,
    "changeinaccountingprincipleaccountingstandardsupdateadopted": "adopted",
    "changeinaccountingprincipleaccountingstandardsupdateadoptiondate": "January 1, 2022",
    "changeinaccountingprincipleaccountingstandardsupdateimmaterialeffect": "no",
    "operatingleaseliability": 21641000,
    "derecognizedbuildtosuitleaseliability": 26500000,
    "propertyplantandequipmentgross": 16605000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 1642000,
    "accruedresearchanddevelopmentcurrent": 8190000,
    "employeerelatedliabilitiescurrent": 2519000,
    "accruedpropertyplantandequipmentcurrent": 2081000,
    "accruedclinicaltrialcurrent": 1473000,
    "accruedseverance": 1463000,
    "leaseliabilitycurrent": 1521000,
    "accruedprofessionalfeescurrent": 390000,
    "otheraccruedliabilitiescurrent": 650000,
    "prepaidresearchanddevelopmentcontracts": 4840000,
    "prepaidclinicaltrial": 2119000,
    "deferredofferingcosts": 724000,
    "prepaidinsurance": 388000,
    "prepaidbonus": 18000,
    "otherassetscurrent": 448000,
    "lesseeoperatingleasetermofcontract": 10,
    "lesseeoperatingleaseoptiontoextend": "The Company has two options to extend the term of the Durham Lease, each for a period of an additional five years.",
    "lesseeoperatingleaseliabilitypaymentsdue": 3500000,
    "escrowdeposit": 2600000,
    "operatingleasecost": 2873000,
    "variableleasecost": 452000,
    "leasecost": 3325000,
    "financeleaseweightedaverageremainingleaseterm1": 3.88,
    "operatingleaseweightedaverageremainingleaseterm1": 11.45,
    "financeleaseweightedaveragediscountratepercent": 0.1051,
    "operatingleaseweightedaveragediscountratepercent": 0.0772,
    "operatingleasepayments": 2486000,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 2819000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 2918000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 3021000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfour": 2485000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfive": 2577000,
    "lesseeoperatingleaseliabilitypaymentsdueafteryearfive": 19721000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 11900000,
    "operatingleaseliabilitycurrent": 1201000,
    "operatingleaseliabilitycurrentstatementoffinancialpositionextensiblelist": "http://fasb.org/us-gaap/2022#AccruedLiabilitiesAndOtherLiabilities",
    "financeleaseliabilitypaymentsduenexttwelvemonths": 454000,
    "financeleaseliabilitypaymentsdueyeartwo": 454000,
    "financeleaseliabilitypaymentsdueyearthree": 454000,
    "financeleaseliabilitypaymentsdueyearfour": 325000,
    "financeleaseliabilitypaymentsdueyearfive": 73000,
    "financeleaseliabilitypaymentsdue": 1760000,
    "financeleaseliabilityundiscountedexcessamount": 308000,
    "financeleaseliability": 1452000,
    "financeleaseliabilitycurrent": 320000,
    "financeleaseliabilitycurrentstatementoffinancialpositionextensiblelist": "http://fasb.org/us-gaap/2022#AccruedLiabilitiesAndOtherLiabilities",
    "financeleaseliabilitynoncurrent": 1132000,
    "financeleaseliabilitynoncurrentstatementoffinancialpositionextensiblelist": "http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent",
    "financeleaseliabilitystatementoffinancialpositionextensiblelist": "http://fasb.org/us-gaap/2022#Liabilities",
    "lineofcreditfacilitymaximumborrowingcapacity": 20000000,
    "debtinstrumentmaturitydaterangeend1": "September 30, 2022",
    "debtinstrumentinterestratestatedpercentage": 0.1125,
    "debtinstrumentunamortizeddiscountnoncurrent": 3000000,
    "interestexpenselongtermdebt": 3700000,
    "longtermdebtmaturitiesrepaymentsofprincipalinyearthree": 6667000,
    "longtermdebtmaturitiesrepaymentsofprincipalinyearfour": 20000000,
    "longtermdebtmaturitiesrepaymentsofprincipalinyearfive": 13333000,
    "debtinstrumentcarryingamount": 40000000,
    "debtinstrumentunamortizeddiscount": 2033000,
    "longtermdebt": 37967000,
    "transactionprice": 36059,
    "deferredrevenue": 33600000,
    "revenueremainingperformanceobligationexpectedtimingofsatisfactionperiod1": 1,
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": "ten-year",
    "sharebasedcompensationarrangementbysharebasedpaymentawardtermsofaward": "the number of shares of common stock that are automatically added on January 1 of each year for a period of up to ten years, commencing on the first January 1 following the IPO and ending on (and including) January 1, 2030, in an amount equal to the lesser of (i) 1.0% of the total number of shares of capital stock outstanding on December 31 of the preceding calendar year, and (ii) 724,000 shares of common stock.",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": "null",
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 4.48,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "four years",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 3.07,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 26400000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": 0.2,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedsharebasedawardsotherthanoptions": 400000,
    "allocatedsharebasedcompensationexpense": 18043000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrantplanadjustmentsandamendmentsinperiod": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrantgrantedinperiod": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrantcancelledinperiod": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.029500000000000002,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": 6.1,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.78,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexpirationsinperiod": 219368,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisablenumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 11.84,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 15.25,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexpirationsinperiodweightedaverageexerciseprice": 24.36,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 24.88,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": 8.9,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": 7.3,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 62000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 85494,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 256481,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 5.28,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 5.28,
    "netincomelossavailabletocommonstockholdersbasic": -166014000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": "null",
    "researchandexperimentationexpendituresamortizedperiod": "15 years",
    "effectiveincometaxratereconciliationtaxcredits": 0.15,
    "excisetaxratepercentage": 0.01,
    "valuationallowancedeferredtaxassetchangeinamount": 42800000,
    "operatinglosscarryforwards": 2900000,
    "deferredtaxassetstaxcreditcarryforwards": 1300000,
    "taxcreditcarryforwardexpirationorduedateyear": 2040,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.0025,
    "effectiveincometaxratereconciliationnondeductibleexpenseresearchanddevelopment": 0.049100000000000005,
    "effectiveincometaxratereconciliationotherpermanentdifferences": -0.0055000000000000005,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.2561,
    "deferredtaxassetsoperatinglosscarryforwards": 45609000,
    "deferredtaxassetstaxdeferredexpensereservesandaccruals": 689000,
    "deferredtaxassetstaxdeferredexpenseother": 1000,
    "deferredtaxassetsgoodwillandintangibleassets": 4607000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefits": 3647000,
    "deferredtaxassetsinprocessresearchanddevelopment": 15563000,
    "deferredtaxassetsleaseliabilities": 4574000,
    "deferredtaxassetsrightofuseassetimpairment": 5525000,
    "deferredtaxassetsgross": 103431000,
    "deferredtaxliabilitiesleasingarrangements": 2308000,
    "deferredtaxliabilitiespropertyplantandequipment": 47000,
    "deferredtaxliabilities": 2355000,
    "deferredtaxassetsvaluationallowance": 101076000,
    "severancecosts1": -2572000,
    "accruedseverancebalance": 1463000,
    "definedcontributionplanemployerdiscretionarycontributionamount": 700000
  },
  {
    "date": "2021-12-30",
    "symbol": "TSHA",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "December 31, 2021",
    "documentfiscalyearfocus": 2021,
    "documentfiscalperiodfocus": "FY",
    "tradingsymbol": "TSHA",
    "entityregistrantname": "Taysha Gene Therapies, Inc.",
    "entitycentralindexkey": 1806310,
    "currentfiscalyearenddate": "--12-31",
    "entitycurrentreportingstatus": "Yes",
    "entityfilercategory": "Non-accelerated filer",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "true",
    "entityextransitionperiod": "false",
    "entityshellcompany": "false",
    "entityfilenumber": "001-39536",
    "entitytaxidentificationnumber": "84-3199512",
    "entityaddressaddressline1": "3000 Pegasus Park Dr",
    "entityaddressaddressline2": "Ste 1430",
    "entityaddresscityortown": "Dallas",
    "entityaddressstateorprovince": "Texas",
    "entityaddresspostalzipcode": 75247,
    "cityareacode": 214,
    "localphonenumber": "612-0000",
    "security12btitle": "Common stock, par value $0.00001 per share",
    "securityexchangename": "The Nasdaq Stock Market LLC",
    "entityincorporationstatecountrycode": "Delaware",
    "entityinteractivedatacurrent": "Yes",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "icfrauditorattestationflag": "false",
    "auditorname": "Deloitte & Touche LLP",
    "auditorlocation": "Dallas, Texas",
    "auditorfirmid": 34,
    "cashandcashequivalentsatcarryingvalue": 149103000,
    "prepaidexpenseandotherassetscurrent": 10499000,
    "assetscurrent": 159602000,
    "restrictedcash": 2637000,
    "deferredcostsleasingnetnoncurrent": 667000,
    "propertyplantandequipmentnet": 50610000,
    "otherassetsnoncurrent": 440000,
    "assets": 213956000,
    "accountspayablecurrent": 21763000,
    "accruedliabilitiesandotherliabilities": 29983000,
    "liabilitiescurrent": 51746000,
    "buildtosuitleaseliability": 25900000,
    "longtermdebtnoncurrent": 37192000,
    "otherliabilitiesnoncurrent": 3735000,
    "liabilities": 118573000,
    "additionalpaidincapital": 331032000,
    "retainedearningsaccumulateddeficit": -235649000,
    "stockholdersequity": -235649000,
    "liabilitiesandstockholdersequity": 213956000,
    "preferredstockparorstatedvaluepershare": 0.00001,
    "preferredstocksharesauthorized": "null",
    "commonstockparorstatedvaluepershare": 0.00001,
    "commonstocksharesauthorized": "null",
    "commonstocksharesissued": "null",
    "commonstocksharesoutstanding": "null",
    "researchanddevelopmentexpense": 3000000,
    "generalandadministrativeexpense": 41324000,
    "operatingexpenses": 173267000,
    "operatingincomeloss": -173267000,
    "interestincomeexpensenonoperatingnet": 172000,
    "interestexpense": 1428000,
    "nonoperatingincomeexpense": -1256000,
    "netincomeloss": -174523000,
    "earningspersharebasicanddiluted": -4.64,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": "null",
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 18604000,
    "stockissuedduringperiodsharesnewissues": "null",
    "issuanceofcommonstockuponvestingandsettlementofrestrictedstockunitsvalue": 712510,
    "profitloss": -174523000,
    "depreciation": 492000,
    "researchanddevelopmentinprocess": 9750000,
    "sharebasedcompensation": 18184000,
    "othernoncashincomeexpense": -388000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 3361000,
    "increasedecreaseinaccountspayable": 14494000,
    "increasedecreaseinaccruedexpenseandotherliabilities": 17542000,
    "increasedecreaseinduetorelatedparties": -8000,
    "netcashprovidedbyusedinoperatingactivities": -117042000,
    "paymentstoacquireinprocessresearchanddevelopment": 6250000,
    "paymentstoacquirepropertyplantandequipment": 15304000,
    "netcashprovidedbyusedininvestingactivities": -21554000,
    "proceedsfromtermloannet": 39957000,
    "paymentofshelfregistrationcosts": 360000,
    "proceedsfrompaymentsforotherfinancingactivities": -514000,
    "netcashprovidedbyusedinfinancingactivities": 39083000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -99513000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 151740000,
    "interestpaidnet": 641000,
    "propertyandequipmentinaccountspayableandaccruedexpenses": 8282000,
    "noncashorpartnoncashacquisitionfixedassetsacquired1": 606000,
    "capitalleaseobligationsincurred": 26250000,
    "capitalexpendituresincurredbutnotyetpaid": 141000,
    "researchanddevelopmentlicensenotyetpaid": 3500000,
    "entityincorporationdateofincorporation": "February 13, 2020",
    "sharesissuedpricepershare": 20,
    "shelfregistrationterm": "P3Y",
    "deferredofferingcosts": 545000,
    "propertyplantandequipmentusefullife": "five years",
    "unrecognizedtaxbenefitsperiodincreasedecrease": 4700000,
    "changeinaccountingprincipleaccountingstandardsupdateadopted": "true",
    "changeinaccountingprincipleaccountingstandardsupdateadoptiondate": "January 1, 2020",
    "changeinaccountingprincipleaccountingstandardsupdateimmaterialeffect": "true",
    "changeinaccountingprincipleaccountingstandardsupdateearlyadoption": "true",
    "propertyplantandequipmentgross": 51109000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 499000,
    "constructioninprogressgross": 2000000,
    "accruedresearchanddevelopmentcurrent": 11895000,
    "employeerelatedliabilitiescurrent": 7703000,
    "accruedlicensefeescurrent": 3500000,
    "accruedpropertyplantandequipmentcurrent": 2644000,
    "accruedclinicaltrialscurrent": 1659000,
    "accruedprofessionalfeescurrent": 1091000,
    "otherliabilitiescurrent": 1491000,
    "prepaidresearchanddevelopmentcontracts": 5218000,
    "prepaidclinicaltrial": 3298000,
    "prepaidbonus": 427000,
    "prepaidinsurance": 148000,
    "otherassetscurrent": 863000,
    "lineofcreditfacilitycurrentborrowingcapacity": 10000000,
    "debtinstrumentunamortizeddiscountnoncurrent": 3000000,
    "interestexpenselongtermdebt": 1100000,
    "longtermdebtmaturitiesrepaymentsofprincipalinyearthree": 6667000,
    "longtermdebtmaturitiesrepaymentsofprincipalinyearfour": 20000000,
    "longtermdebtmaturitiesrepaymentsofprincipalinyearfive": 13333000,
    "debtinstrumentcarryingamount": 40000000,
    "debtinstrumentunamortizeddiscount": 2808000,
    "longtermdebt": 37192000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": "P10Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardtermsofaward": "the number of shares of common stock that are automatically added on January 1st of each year for a period of up to ten years, commencing on the first January 1 following the IPO Date and ending on (and including) January 1, 2030, in an amount equal to the lesser of (i) one percent (1.0%) of the total number of shares of capital stock outstanding on December 31st of the preceding calendar year, and (ii) 724,000 shares of common stock.",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": "null",
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 24.99,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "four years",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 16.33,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 44700000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": 0.6,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedsharebasedawardsotherthanoptions": 1800000,
    "allocatedsharebasedcompensationexpense": 18184000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0084,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P6Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.75,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 217480,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisablenumber": 243722,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 24.13,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 26.07,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 21.3,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P9Y2M12D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P8Y8M12D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 341975,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 427083,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeitedinperiod": 250778,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 5.28,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 5.28,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeituresweightedaveragegrantdatefairvalue": 5.25,
    "netincomelossavailabletocommonstockholdersbasic": -174523000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": "null",
    "valuationallowancedeferredtaxassetchangeinamount": 48400000,
    "operatinglosscarryforwards": 4099999.9999999995,
    "deferredtaxassetstaxcreditcarryforwards": 1000000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.002,
    "effectiveincometaxratereconciliationnondeductibleexpenseresearchanddevelopment": 0.0768,
    "effectiveincometaxratereconciliationotherpermanentdifferences": -0.011200000000000002,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.2776,
    "deferredtaxassetsoperatinglosscarryforwards": 37005000,
    "deferredtaxassetstaxdeferredexpensereservesandaccruals": 1467000,
    "deferredtaxassetstaxdeferredexpenseother": 103000,
    "deferredtaxassetsgoodwillandintangibleassets": 4169000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefits": 674000,
    "deferredtaxassetsgross": 58231000,
    "deferredtaxassetsvaluationallowance": 58231000,
    "escrowdeposit": 2600000,
    "operatingleasesinitialdirectcosts": 800000,
    "buildtosuitasset": 26300000,
    "builttosuitleaseliability": 26300000,
    "equipmentpurchasesandbuildoutofleasedfacility": 45800000,
    "lesseeoperatingleaseliabilitypaymentsdue": 52153000,
    "leaseincentivereceivable": 600000,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 4848000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 4201000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 4301000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfour": 4372000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfive": 3868000,
    "lesseeoperatingleaseliabilitypaymentsdueafteryearfive": 30563000,
    "definedcontributionplanemployerdiscretionarycontributionamount": 400000
  },
  {
    "date": "2020-12-30",
    "symbol": "TSHA",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "2020-12-31",
    "documentfiscalyearfocus": 2020,
    "documentfiscalperiodfocus": "FY",
    "tradingsymbol": "TSHA",
    "entityregistrantname": "Taysha Gene Therapies, Inc.",
    "entitycentralindexkey": 1806310,
    "currentfiscalyearenddate": "--12-31",
    "entitycurrentreportingstatus": "Yes",
    "entityfilercategory": "Non-accelerated Filer",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "true",
    "entityextransitionperiod": "false",
    "entityshellcompany": "false",
    "entityfilenumber": "001-39536",
    "entitytaxidentificationnumber": "84-3199512",
    "entityaddressaddressline1": "2280 Inwood Road",
    "entityaddresscityortown": "Dallas",
    "entityaddressstateorprovince": "TX",
    "entityaddresspostalzipcode": 75235,
    "cityareacode": 214,
    "localphonenumber": "612-0000",
    "security12btitle": "Common stock, par value $0.00001 per share",
    "securityexchangename": "NASDAQ",
    "entityincorporationstatecountrycode": "DE",
    "entityinteractivedatacurrent": "Yes",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "icfrauditorattestationflag": "false",
    "cashandcashequivalentsatcarryingvalue": 251253000,
    "prepaidexpenseandotherassetscurrent": 6626000,
    "assetscurrent": 257879000,
    "deferredcostsleasingnetnoncurrent": 715000,
    "propertyplantandequipmentnet": 287000,
    "assets": 258881000,
    "accountspayablecurrent": 1994000,
    "accruedliabilitiesandotherliabilities": 5135000,
    "liabilitiescurrent": 7129000,
    "otherliabilitiesnoncurrent": 450000,
    "liabilities": 7579000,
    "additionalpaidincapital": 312428000,
    "retainedearningsaccumulateddeficit": -61126000,
    "stockholdersequity": -61126000,
    "liabilitiesandstockholdersequity": 258881000,
    "preferredstockparorstatedvaluepershare": 0.00001,
    "preferredstocksharesauthorized": 10000000,
    "commonstockparorstatedvaluepershare": 0.00001,
    "commonstocksharesauthorized": 200000000,
    "commonstocksharesissued": 37761435,
    "commonstocksharesoutstanding": 37761435,
    "researchanddevelopmentexpense": 7000000,
    "generalandadministrativeexpense": 11109000,
    "operatingexpenses": 43002000,
    "operatingincomeloss": -43002000,
    "changeinfairvalueofpreferredstocktrancheliability": -17030000,
    "interestincomeexpensenonoperatingnet": 49000,
    "interestexpense": 28000,
    "nonoperatingincomeexpense": -17009000,
    "netincomeloss": -60011000,
    "earningspersharebasicanddiluted": -3.4,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 17665683,
    "temporaryequitystockissuedduringperiodvaluenewissues": 95815000,
    "temporaryequitystockissuedduringperiodsharesnewissues": 5647048,
    "reclassificationoftemporaryequitypreferredstocktrancheliabilityuponissuanceofmilestoneshares": 18080000,
    "temporaryequityconversionvalueofconvertiblepreferredstocktocommonstock": -95815000,
    "temporaryequityconversionsharesofconvertiblepreferredstocktocommonstock": 5647048,
    "stockissuedduringperiodvalueconversionofconvertiblesecurities": 142240000,
    "stockissuedduringperiodsharesconversionofconvertiblesecurities": 17047378,
    "stockissuedduringperiodvaluenewissues": 165854000,
    "stockissuedduringperiodsharesnewissues": 9050000,
    "stockissuedduringperiodsharesrestrictedstockawardnetofforfeitures": 769058,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 3354000,
    "temporaryequitystockofferingcosts": 185000,
    "adjustmentstoadditionalpaidincapitalstockissuedissuancecosts": 15145000,
    "temporaryequitystockissuanceofpreferredstocktrancheliability": 1050000,
    "profitloss": -60011000,
    "depreciation": 9000,
    "researchanddevelopmentinprocess": 9000000,
    "sharebasedcompensation": 3354000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 6585000,
    "increasedecreaseinaccountspayable": 1961000,
    "increasedecreaseinaccruedexpenseandotherliabilities": 4513000,
    "netcashprovidedbyusedinoperatingactivities": -30729000,
    "paymentstoacquireinprocessresearchanddevelopment": 9000000,
    "paymentstoacquirepropertyplantandequipment": 82000,
    "netcashprovidedbyusedininvestingactivities": -9082000,
    "proceedsfromissuanceinitialpublicoffering": 165854000,
    "proceedsfromissuanceofconvertiblepreferredstock": 95815000,
    "proceedsfromrelatedpartydebt": 1673000,
    "repaymentsofrelatedpartydebt": 1673000,
    "netcashprovidedbyusedinfinancingactivities": 291064000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": 251253000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 251253000,
    "interestpaidnet": 28000,
    "propertyandequipmentinaccountspayableandaccruedexpenses": 214000,
    "reclassificationofpreferredstockliabilityuponissuancecosts": 18080000,
    "allocationofpreferredstocktrancheliability": 1050000,
    "conversionofconvertiblepreferredstocktocommonstock": 142240000,
    "entityincorporationdateofincorporation": "2020-02-13",
    "sharesissuedpricepershare": 20,
    "propertyplantandequipmentusefullife": "P5Y",
    "propertyplantandequipmentgross": 296000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 9000,
    "accruedresearchanddevelopmentcurrent": 2106000,
    "employeerelatedliabilitiescurrent": 1766000,
    "accruedprofessionalfeescurrent": 999000,
    "otherliabilitiescurrent": 264000,
    "prepaidinsurance": 2480000,
    "prepaidresearchanddevelopmentcontracts": 2462000,
    "prepaidclinicaltrial": 944000,
    "otherassetscurrent": 740000,
    "licensefee": 3000000,
    "interestexpenserelatedparty": 28000,
    "duetorelatedpartiescurrent": 9800,
    "amountowedforissuancesettledmonthandyear": "2020-07",
    "allocatedsharebasedcompensationexpense": 3354000,
    "fairvaluemeasurementwithunobservableinputsreconciliationrecurringbasisliabilityissues": 1050000,
    "fairvaluemeasurementwithunobservableinputsreconciliationrecurringbasisliabilitygainlossincludedinearnings": -17030000,
    "fairvaluemeasurementwithunobservableinputsreconciliationrecurringbasisliabilitysettlements": 18080000,
    "commonstockcapitalsharesreservedforfutureissuance": 2941509,
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": "P10Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardtermsofaward": "The number of shares of common stock that are automatically added on January 1st of each year for a period of up to ten years, commencing on the first January 1 following the IPO Date and ending on (and including) January 1, 2030, in an amount equal to the lesser of (i) one percent (1.0%) of the total number of shares of capital stock outstanding on December 31st of the preceding calendar year, and (ii) 724,000 shares of common stock",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 674842,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 20.68,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "P4Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsreplacementunitsgrantsinperiod": 2518932,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognized": 13200000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 13.73,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 8800000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P2Y3M18D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 769058,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedsharebasedawardsotherthanoptions": 3200000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 5.28,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0054,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P6Y2M12D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.77,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 674842,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": 674842,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisablenumber": 12054,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 20.68,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableweightedaverageexerciseprice": 20.68,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 20.25,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P9Y9M18D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": "P9Y9M18D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P9Y9M18D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 3953000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingaggregateintrinsicvalue": 3953000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 76000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 769058,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 5.28,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsreplacementunitsgrantsinperiodweightedaveragegrantdatefairvalue": 5.25,
    "netincomelossavailabletocommonstockholdersbasic": -60011000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 4293953,
    "netoperatinglosscarryforwardpercentage": 0.8,
    "taxcutsandjobsactadjustedtaxableincomelimitationpercentage": 0.5,
    "valuationallowancedeferredtaxassetchangeinamount": 9500000,
    "operatinglosscarryforwards": 27700000,
    "deferredtaxassetstaxcreditcarryforwards": 100000,
    "taxcreditcarryforwardexpirationorduedateyear": 2040,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.0006,
    "effectiveincometaxratereconciliationgeneralbusinesscredits": 0.0106,
    "effectiveincometaxratereconciliationotherpermanentdifferences": -0.0025,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.1591,
    "effectiveincometaxratereconciliationchangeinfairvalueoftrancheliability": -0.0596,
    "deferredtaxassetsoperatinglosscarryforwards": 5810000,
    "deferredtaxassetstaxdeferredexpensereservesandaccruals": 334000,
    "deferredtaxassetstaxdeferredexpenseother": 21000,
    "deferredtaxassetsgoodwillandintangibleassets": 2390000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefits": 555000,
    "deferredtaxassetsgross": 9782000,
    "deferredtaxassetsvaluationallowance": 9782000,
    "operatingleasesinitialdirectcosts": 800000,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 314000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 1282000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 1317000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfour": 1354000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfive": 1391000,
    "lesseeoperatingleaseliabilitypaymentsdueafteryearfive": 17599000,
    "lesseeoperatingleaseliabilitypaymentsdue": 23257000
  }
]